D. Visca (Tradate, Italy), B. Alcazar Navarrete (Cájar, Spain), P. Pignatti (Pavia, Italy), A. Spanevello (Milan, Italy)
Exhaled nitric oxide in overweight and obese asthma patients compared to normal weight asthmatic patients.
K. Ansarin (Tabriz, Islamic Republic of Iran), A. Seyedrezazadeh (Tabriz, Islamic Republic of Iran)
|  |
Usefulness of fraction of exhaled nitric oxide and asthma management questionnaires in predicting a future risk of asthma exacerbation
M. Uematsu (Fukushima, Japan), J. Saito (Fukushima, Japan), S. Sato (Fukushima, Japan), A. Fukuhara (Fukushima, Japan), Y. Suzuki (Fukushima, Japan), R. Togawa (Fukushima, Japan), Y. Sato (Fukushima, Japan), T. Nikaido (Fukushima, Japan), Y. Tanino (Fukushima, Japan), Y. Shibata (Fukushima, Japan)
| |
Airway and systemic nitric oxide pathway in COPD
P. Horváth (Budapest, Hungary), B. Csoma (Budapest, Hungary), L. Nagy (Debrecen, Hungary), B. Tóth (Debrecen, Hungary), T. Tábi (Budapest, Hungary), G. Szucs (Budapest, Hungary), Z. Komlósi (Budapest, Hungary), V. Müller (Budapest, Hungary), G. Losonczy (Budapest, Hungary), Z. Lázár (Budapest, Hungary)
| |
Stability of FENO50 in a COPD cohort in Sweden over 2-year follow-up
M. Högman (Uppsala, Sweden), B. Ställberg (Uppsala, Sweden), K. Lisspers (Uppsala, Sweden), H. Hedensström (Uppsala, Sweden), K. Bröms (Gävle, Sweden), C. Janson (Uppsala, Sweden), A. Malinovschi (Uppsala, Sweden)
| |
Spirometry and FeNO in Children with Mild-Moderate and Severe Asthma.
G. Andrada (Buenos Aires, Argentina), M. Vocos (Buenos Aires, Argentina), V. Giubergia (Buenos Aires, Argentina), G. Donth Leger (Buenos Aires, Argentina), L. Belen (Buenos Aires, Argentina), V. Carlos (Buenos Aires, Argentina), A. Verónica (Buenos Aires, Argentina), P. Gabriela (Buenos Aires, Argentina), K. Anahí (Buenos Aires, Argentina), R. Marcela (Buenos Aires, Argentina), P. Doris (Buenos Aires, Argentina), C. Claudio (Buenos Aires, Argentina), F. Juan (Buenos Aires, Argentina)
|  |
Ex-smokers with frequent COPD exacerbations have low FENO in stable condition
A. Thornadtsson (Gävle, Sweden), A. Malinovschi (Uppsala, Sweden), K. Bröms (Gävle, Sweden), C. Janson (Uppsala, Sweden), K. Lisspers (Uppsala, Sweden), B. Ställberg (Uppsala, Sweden), H. Hedenström (Uppsala, Sweden), M. Högman (Uppsala, Sweden)
| |
Combined effects of type 2 inflammation and lung function on exhaled nitric oxide ability to reflect asthma control
L. Demey (Brussels, Belgium), A. Van Muylem (Brussels, Belgium), S. Perez-Bogerd (Brussels, Belgium), A. Haccuria (Brussels, Belgium), A. Michils (Brussels, Belgium)
| |
Comparison of three different exhaled nitric oxide analyzers in asthma and COPD
M. Maniscalco (Telese, Italy), S. Fuschillo (Telese, Italy), M. Mosella (Telese, Italy), S. Accardo (Telese, Italy), A. De Felice (Telese, Italy), C. Gaudiosi (Telese, Italy), M. Martucci (Telese, Italy), A. Molino (Napoli, Italy)
| |
Simultaneous estimation of partitioned FeNO sources and airway dimensions with tidal breath data
P. Muchmore (Los Angeles, United States of America), S. Xu (Los Angeles, United States of America), E. Rappaport (Los Angeles, United States of America), S. Eckel (Los Angeles, United States of America), F. Gilliland (Los Angeles, United States of America)
| |
Monitoring of forced expiratory Nitric Oxide (FeNO) during Winter swimming
G. Becher (Bernau, Germany), S. Hummel (Heiligendamm, Germany)
| |
Fractional exhaled nitric oxide (FeNO), Impulse Oscilometry (IOS) and clinical status in 4 to 7 years old asthmatic children
G. Andrada (Buenos Aires, Argentina), G. Donth (Buenos Aires, Argentina), M. Roque (Buenos Aires, Argentina), M. Vocos (Buenos Aires, Argentina), D. Primrose (Buenos Aires, Argentina), C. Velazco Suarez (Buenos Aires, Argentina), A. Kruger (Buenos Aires, Argentina), J. Figueroa (Buenos Aires, Argentina)
| |
ASSOCIATION BETWEEN EXHALED NITRIC OXIDE AND NASAL POLYPOSISIN SEVERE ASTHMA
M. Maniscalco (Telese , Italy), C. Calabrese (Napoli (NA), Italy), M. D'Amato (Napoli (NA), Italy), A. Molino (Napoli (NA), Italy), M. Aliani (Bari, Italy), A. De Felice (Telese, Italy), F. Ricciardolo (Torino, Italy), E. Carpagnano (Foggia, Italy)
| |
The relationship between fractional exhaled nitric oxide and asthma symptom scores in patients on mepolizumab
D. Jackson (London, United Kingdom), L. Shackshaft (London, United Kingdom), L. Green (London, United Kingdom), C. Roxas (London, United Kingdom), M. Fernandes (London, United Kingdom), L. Thompson (London, United Kingdom), G. D'Ancona (London, United Kingdom), M. Elstad (London, United Kingdom), A. Douiri (London, United Kingdom), A. Nanzer-Kelly (London, United Kingdom), B. Kent (London, United Kingdom)
| |
The acceptibility and feasibility of FeNo-based asthma management in Australian antenatal clinics- A qualitative descriptive study.
K. McLaughlin (Newcastle, Australia), M. Jensen (Newcastle, Australia), M. Foureur (Newcastle, Australia), P. Gibson (Newcastle, Australia), V. Murphy (Newcastle, Australia)
| |
Fractional exhaled nitric oxide in patients with chronic obstructive pulmonary disease
F. Yangui (Tunis, Tunisia), H. Rjab (Tunis, Tunisia), N. Mbarek (Tunis, Tunisia), S. Bousselmi (Tunis, Tunisia), M. Triki (Tunis, Tunisia), M. Charfi (Tunis, Tunisia)
| |
Cost analysis for therapy management of asthmatics with FeNO in primary care in Germany
S. Wiener (Stuttgart, Germany), T. Wollensak (Stuttgart, Germany), S. Wegner (Waiblingen, Germany), C. Ernst (Stuttgart, Germany)
| |
Changes in the cellular composition of induced sputum in patients with asthma-COPD overlap
E. Kochegarova (Blagoveshchensk, Russian Federation), A. Prikhodko (Blagoveshchensk, Russian Federation), J. Perelman (Blagoveshchensk, Russian Federation), A. Pirogov (Blagoveshchensk, Russian Federation), V. Kolosov (Blagoveshchensk, Russian Federation), N. Perelman (Blagoveshchensk, Russian Federation), V. Pavlenko (Blagoveshchensk, Russian Federation), S. Naryshkina (Blagoveshchensk, Russian Federation)
| |
Asthma COPD overlap,Diagnostic stability and inflammatory characteristics
G. Patentalakis (Athens, Greece), P. Bakakos (Athens, Greece), A. Papaporfyriou (Athens, Greece), G. Papatheodorou (Athens, Greece), G. Hillas (Athens, Greece), K. Ostikas (Athens, Greece), S. Papiris (Athens, Greece), N. Koulouris (Athens, Greece), S. Loukides (Athens, Greece)
| |
Are we missing asthma COPD overlap (ACO) diagnosis among patient with COPD?Alameeri Amel(1), Dudina Alexandra(1) , Stephen Lane(1), Kennedy Merian(2)
A. Alameeri (dublin, Ireland)
| |
Prevalence and demographics of asthma - COPD overlap (ACO) among asthma and COPD patients in the pulmonary clinic of the University of the Philippines - Philippine General Hospital
A. Jaen (Manila City, Philippines), L. Fernandez (Manila City, Philippines), I. Tan (Manila City, Philippines), A. Wang (Manila City, Philippines), R. Villalobos (Manila City, Philippines), M. Cuñada (Manila City, Philippines)
| |